Boeing has burned through $20.9 billion of free cash flow over the last five fiscal years and still trades at 91x earnings on a margin profile that has not recovered. The investment-grade balance sheet is a ladder pointed at the ceiling.
Boeing closed 2025 with negative $1.9 billion in free cash flow. That follows negative $14.4 billion in 2024, positive $4.4 billion in 2023, negative $3.5 billion in 2022, and negative $4.4 billion in 2021. Five fiscal years. Cumulative free cash flow of negative $20.9 billion. The company has not produced a normalised year of operating cash generation since 2018.
At $250 a share, Boeing is being priced for a recovery that the cycle has never delivered. The trailing P/E sits at 91.5. The forward P/E, which already prices in the recovery narrative, is 163.9. Operating margin of 1.7% is, frankly, the kind of margin a low-cost manufacturing business produces, not a duopoly aerospace platform with $580 billion in commercial backlog.
The argument is direct. Boeing is being valued on a free cash flow figure ($10 billion annually, the long-cited bull case target) that the company has not earned in seven years and currently has no credible path to. The capital allocation flexibility the bull case requires (debt paydown, restored buybacks, eventually a dividend) is at least three years away under the most generous assumptions. The valuation is wrong.
The bull case for Boeing rests on three pillars. The commercial backlog stands at over $500 billion across the 737, 787, and 777X programmes. The defence portfolio adds another $60 billion. Annual revenue at full production scales toward $100 billion. The narrative says: production rates normalise, cash conversion follows.
Backlogs do not generate cash. Deliveries do. And the data on deliveries is uncomfortable. Boeing produced approximately 348 commercial aircraft in 2025, well below the 600 plus a year run rate that the cash flow target requires. The 737 MAX line is rebuilding from the FAA-imposed cap of 38 per month following the door plug incident in early 2024. Reaching 50 per month, the production rate consistent with the bull case, requires regulatory clearance the company does not currently have.
The 787 line continues to absorb concession costs from accumulated quality issues. The 777X programme is approximately five years late to first delivery, with certification still pending. None of these are short-cycle issues. Each is a multi-year operational reset.
The Capital Desk has run the cash conversion mathematics across every major aerospace cycle. Working capital absorption during the production ramp typically runs at 20-25% of incremental revenue. Boeing's working capital build during a normalised ramp from 348 to 600 deliveries implies $8-10 billion of incremental working capital before any of that revenue converts to free cash flow. The company has guided to 2027 as the year free cash flow normalises. The math says 2028 at the earliest, and only if every operational milestone is hit on schedule.
TickerXray Report
Get the complete Boeing report with all 12 quantitative models, AI-generated investment thesis, and real-time data.
Boeing carries approximately $54 billion of total debt against $26 billion of cash and equivalents. Net debt of $28 billion is manageable in a normalised cash-generating business. It is heavy in a business burning cash. The company has used the equity markets twice in the last 24 months to recapitalise (the October 2024 raise priced at $143 per share added $24 billion of equity).
The ratings agencies have Boeing one notch above junk. Moody's Baa3, S&P BBB minus. Both with negative outlook. A downgrade to high yield is not theoretical; it is contingent on whether the company can demonstrate sustained positive free cash flow within four quarters. The October raise bought time, not vindication.
Dividend coverage does not exist. Boeing suspended the dividend in March 2020. The bull case envisions reinstatement in 2027 or 2028. The math here is unforgiving: the prior dividend cost approximately $4.6 billion annually. To support that distribution at investment-grade leverage targets, the company needs $8-9 billion of recurring free cash flow. The current run rate is negative.
Share buybacks are similarly impaired. Boeing repurchased nothing in 2025. The company has issued approximately 220 million additional shares since 2020 to fund operations. The share count has expanded by 38% over six years, diluting any potential per-share earnings recovery. By comparison, Lockheed Martin reduced share count by 12% over the same period while maintaining a continuous dividend. Capital allocation is not a question of intent; it is a question of cash that has not arrived.
The bull retort is that backlog of this size, in a structural duopoly with Airbus, eventually converts. There are no aircraft alternatives. The fleet replacement cycle will run for a decade. Customers cannot cancel without forfeiting deposits. All true.
The problem is that the same was said in 2019, in 2021, and again in 2023. Each time, the cash conversion timeline slipped 12 to 18 months. The recovery story has been the consensus view since the second 737 MAX grounding lifted, and the consensus has been wrong every quarter since. The pattern is consistent: management guides to a free cash flow normalisation 18-24 months out, the date slips, the narrative resets. Across three discrete recovery cycles (post-MAX 1, post-COVID, post-door-plug), the average slippage has been 14 months.
The bull case is correct on the supply-demand setup. It is wrong on the timeline, and timeline is everything in a stock that pays no dividend, generates no cash, and is priced for execution that has not occurred.
Boeing is not a 91x trailing earnings business and never was. The market is pricing in $10 billion of annual free cash flow that the company has not earned, at a delivery cadence the regulator has not authorised, with a working capital ramp that has not begun. The setup requires three things to break right simultaneously: 737 production at 50 per month, 787 deliveries clearing the concession overhang, and 777X certification by mid-2027. Across three previous recovery cycles, none of those conditions has been met within the original timeline. The base rate for the bull case being right is one in three.
Fair value, on a normalised free cash flow assumption of $7 billion (not $10 billion) at a 6% yield, is approximately $190 per share. The current $250 implies a free cash flow recovery the company has missed in every prior cycle. We see a year where the multiple compresses before the cash flow arrives, and the floor under the stock is closer to $180 than $230. Bearish. The capital allocation flexibility the bull case requires is at least 18 months further away than the current quote implies.
Full forensic analysis of Boeing
+ 6 more models included
150,000+ stocks covered
Global coverage across 60+ exchanges. Every report includes all 12 quantitative models and AI analysis.
View plansEvery report runs 12 quantitative models and generates an AI investment thesis. From Piotroski scores to manipulation detection -- get the full picture in seconds.
12 forensic models
Piotroski, Altman, Beneish, DuPont & more
AI investment thesis
Synthesized outlook on every stock
Manipulation detection
Spot red flags before they hit the news
150,000+ tickers
Global coverage across 60+ exchanges
Expected return
Forward return projections for every stock
Real-time data
Live prices, insider trades, news sentiment
Free accounts get 1 report per month. Pro gets unlimited.
A 200-plane Beijing commitment lifted the narrative, not the financials. Free cash flow has been negative in three of the last five years, capex has tripled since 2021, and the math still doesn't work at $240 per share.
Boeing reappeared on the Dow leadership list this week alongside Apple and Nvidia. The technical picture is real, but the fundamental case underneath it is more complicated than the chart implies.
Revenue grew 35%, operating margin stayed negative at 3.2%, and free cash flow of minus $1.9 billion is the fourth negative-FCF year in five. The turnaround is not here yet.